First person – Zongwang Zhang


 First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Zongwang Zhang is first author on ‘ A DUSP6 inhibitor suppresses inflammatory cardiac remodeling and improves heart function after myocardial infarction’, published in DMM. Zongwang is a PhD student in the lab of Jing-Wei Xiong at Peking University, Beijing, China, investigating therapeutic targets and drugs for cardiovascular diseases.